Measles studies in the macaque model

Current Topics in Microbiology and Immunology

Volumn 330, Issue , 2009, Pages 55-72

  De Swart, R L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; MEASLES VACCINE;

ANTIBODY RESPONSE; CELL LINE; CHO CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MACACA; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPECIES DIFFERENCE; VIRUS ATTENUATION; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY; MACACA; MEASLES; MEASLES VACCINE; MEASLES VIRUS; VACCINES, ATTENUATED;

ANIMALIA; MACACA; MEASLES VIRUS; PRIMATES;

EID: 58249096443     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-70617-5_3     Document Type: Review

References (96)

1. Albrecht P, Lorenz D, Klutch MJ, Vickers JH, Ennis FA (1980) Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect Immun 27:969-978
2. Albrecht P, Lorenz D, Klutch MJ (1981) Encephalitogenicity of measles virus in marmosets. Infect Immun 34:581-587
3. Anderson JF, Goldberger J (1911) Experimental measles in the monkey: a supplemental note. Public Health Reports 26:887-895
4. Auwaerter PG, Rota PA, Elkins WR, Adams RJ, DeLozier T, Shi Y, Bellini WJ, Murphy BR, Griffin DE (1999) Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis 180:950-958
5. Bankamp B, Hodge G, McChesney MB, Bellini WJ, Rota PA (2008) Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 373:39-50
6. Blake FG, Trask Jr JD (1921a) Studies on measles. I. Susceptibility of monkeys to the virus of measles. J Exp Med 33:385-412
7. Blake FG, Trask Jr JD (1921b) Studies on measles. II. Symptomatology and pathology in monkeys experimentally infected. J Exp Med 33:413-422
8. Blake FG, Trask Jr JD (1921c) Studies on measles. III. Acquired immunity following experimental measles. J Exp Med 33:621-626
9. Burnet FM (1968) Measles as an index of immunological function. Lancet 292:610-613
10. Buynak EB, Peck HM, Creamer AA, Goldner H, Hilleman MR (1962) Differentiation of virulent from avirulent measles strains. Am J Dis Child 103:290-303
11. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA (1990) Measles antibody: reevaluation of protective titers. J Infect Dis 162:1036-1042
12. Condack C, Grivel J-C, Devaux P, Margolis L, Cattaneo R (2007) Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196:541-549
13. Cutts FT, Clements CJ, Bennett JV (1997) Alternative routes of measles immunization: a review. Biologicals 25:323-338
14. De Swart RL, Kuiken T, Timmerman HH, Van Amerongen G, van den Hoogen BG, Vos HW, Neijens HJ, Andeweg AC, Osterhaus ADME (2002) Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J Virol 76:11561-11569
15. De Swart RL, Kuiken T, Fernandez de Castro J, Papania MJ, Valdespino JL, Minor P, Witham C, Yüksel S, Vos HW, Van Amerongen G, Osterhaus ADME (2006) Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety. Vaccine 24:6424-6436
16. De Swart RL, LiCalsi C, Quirk AV, Van Amerongen G, Nodelman V, Alcock R, Yüksel S, Ward GH, Hardy JG, Vos HW, Witham CL, Grainger CI, Kuiken T, Greenspan BJ, Gard TG, Osterhaus ADME (2007a) Measles vaccination of macaques by dry powder inhalation. Vaccine 25:1183-1190
17. + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3:e178
18. De Swart RL, van den Hoogen BG, Kuiken T, Herfst S, Van Amerongen G, Yüksel S, Sprong L, Osterhaus ADME (2007c) Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 25:8518-8528
19. Dilraj A, Cutts FT, Fernandez de Castro J, Wheeler JG, Brown D, Roth C, Coovadia HM, Bennett JV (2000) Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 355:798-803
20. El Mubarak HS, Yüksel S, Van Amerongen G, Mukhtar MM, De Swart RL, Osterhaus ADME (2007) Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J Gen Virol 88:2028-2034
21. Enders JF, Peebles TC (1954) Propagation in tissue cultures of cytophatic agents from patients with measles. Proc Soc Exp Biol Med 86:277-286
22. Enders JF, Katz SL, Milovanovic MV, Holloway A (1960) Studies on an attenuated measles-virus vaccine I. Development and preparation of the vaccine: techniques for assay of effects of vaccination. N Engl J Med 263:153-159
23. Finkeldey W (1931) Über Riesenzellbefunde in den Gaumenmandeln, zugleich ein Beitrag zur Histopathologie der Mandelveränderungen im Maserninkubationsstadium. Virchows Arch 281:323-329
24. Foege WH, Leland OS, Mollohan CS, Fulginiti VA, Henderson DA, Kempe CH (1965) Inactivated measles-virus vaccine. Public Health Reports 80:60-64
25. Fulginiti VA, Eller JJ, Downte AW, Kempe CH (1967) Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202:1075-1080
26. Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G (1969) Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol 89:435-448
27. Goldberger J, Anderson JF (1911) An experimental demonstration of the presence of the virus of measles in the mixed buccal and nasal secretions. J Am Med Assoc 57:476-478
28. Griffin DE, Ward BJ, Esolen LM (1994) Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 170 [Suppl. 1]:S24-S31
29. Hall WC, Kovatch RM, Herman PH, Fox JG (1971) Pathology of measles in rhesus monkeys. Vet Pathol 8:307-319
30. Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y (2002) SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76:6743-6749
31. Hicks JT, Sullivan JL, Albrecht P (1977) Immune responses during measles infection in immunosuppressed rhesus monkeys. J Immunol 119:1452-1456
32. Hilleman MR, Stokes J, Buynak EB, Reilly CM, Hampil B (1962) Immunogenic response to killed measles-virus vaccine. Am J Dis Child 103:274-281
33. Hime JM, Keymer IF (1975) Measles in recently imported colobus monkeys (Colobus guereza). Vet Rec 97:392
34. Hirsch RL, Griffin DE, Johnson RT, Cooper SJ, Lindo de Soriano I, Roedenbeck S, Vaisberg A (1984) Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 31:1-12
35. Hoffman SJ, Polack FP, Hauer DA, Griffin DE (2003a) Measles virus infection of rhesus macaques affects neutrophil expression of IL-12 and IL-10. Viral Immunol 16:369-379
36. Hoffman SJ, Polack FP, Hauer DA, Singh M, Billeter MA, Adams RJ, Griffin DE (2003b) Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses. J Infect Dis 188:1553-1561
37. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-421
38. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89:422-434
39. Kobune F, Sakata H, Sugiura A (1990) Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 64:700-705
40. Kobune F, Takahashi H, Terao K, Ohkawa T, Ami Y, Suzaki Y, Nagata N, Sakata H, Yamanouchi K, Kai C (1996) Nonhuman primate models of measles. Lab Anim Sci 46:315-320
41. Levy BM, Mirkovic RR (1971) An epizootic of measles in a marmoset colony. Lab Anim Sci 21:33-39
42. LiCalsi C, Maniaci MJ, Christensen T, Phillips E, Ward GH, Witham C (2001) A powder formulation of measles vaccine for aerosol delivery. Vaccine 19:2629-2636
43. MacArthur JA, Mann PG, Oreffo V, Scott GBD (1979) Measles in monkeys: an epidemiological study. J Hyg 83:207-212
44. Marshall E, Enserink M (2004) Caution urged on SARS vaccines. Science 303:944-946
45. McChesney MB, Fujinami RS, Lerche NW, Marx PA, Oldstone MBA (1989) Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis 159:757-760
46. McChesney MB, Miller CJ, Rota PA, Zhu Y, Antipa L, Lerche NW, Ahmed R, Bellini WJ (1997) Experimental measles I. Pathogenesis in the normal and the immunized host. Virology 233:74-84
47. Meyer HM, Brooks BE, Douglas RD, Rogers NG (1962) Ecology in measles in monkeys. Am J Dis Child 103:138-143
48. Mongkolsapaya J, Jaye A, Callan MFC, Magnusen AF, McMichael AJ, Whittle HC (1999) Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 73:67-71
49. Moss WJ, Ryon JJ, Monze M, Griffin DE (2002) Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis 186:879-887
50. Nii S, Kamahora J, Mori Y, Takahashi M, Nishimura S, Okuno Y (1964a) Experimental pathology of measles in monkeys. Biken J 6:271-297
51. Nii S, Kamahora J, Okuno Y, Nishimura S, Kato S, Aoyama Y (1964b) Studies on the biological effects of live attenuated measles vaccines in monkeys. Biken J 7:65-69
52. Norrby E, Carlstrom G, Lagercrantz R, Gard S (1964) Measles vaccination II. Antibody titers 8 to 9 months after vaccination with an inactivated vaccine. Acta Paediat 53:533-540
53. Norrby E, Enders-Ruckle G, Ter Meulen V (1975) Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis 132:262-269
54. Okada H, Kobune F, Sato TA, Kohama T, Takeuchi Y, Abe T, Takayama N, Tsuchiya T, Tashiro M (2000) Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 145:905-920
55. Pahar B, Li J, McChesney MB (2005) Detection of T cell memory to measles virus in experimentally infected rhesus macaques by cytokine flow cytometry. J Immunol Methods 304:174-183
56. Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE, Perri S, Polo JM, Griffin DE (2005) Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc Natl Acad Sci U S A 102:11581-11588
57. Pasetti MF, Resendiz-Albor A, Ramirez K, Stout R, Papania M, Adams RJ, Polack FP, Ward BJ, Burt D, Chabot S, Ulmer J, Barry EM, Levine MM (2007) Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques. Clin Pharmacol Ther 82:672-685
58. Peebles TC, McCarthy K, Enders JF, Holloway A (1957) Behavior of monkeys after inoculation of virus derived from patients with measles and propagated in tissue culture together with observations on spontaneous infections of these animals by an agent exhibiting similar antigenic properties. J Immunol 78:63-74
59. + lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol 77:4396-4400
60. Permar SR, Klumpp SA, Mansfield KG, Carville AA, Gorgone DA, Lifton MA, Schmitz JE, Reimann KA, Polack FP, Griffin DE, Letvin NL (2004) Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis 190:998-1005
61. Polack FP, Auwaerter PG, Lee SH, Nousari HC, Valsamakis A, Leiferman KM, Diwan A, Adams RJ, Griffin DE (1999) Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 5:629-634
62. Polack FP, Lee SH, Permar S, Manyara E, Nousari HC, Jeng Y, Mustafa F, Valsamakis A, Adams RJ, Robinson HL, Griffin D (2000) Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat Med 6:776-781
63. Polack FP, Hoffman SJ, Moss WJ, Griffin DE (2002) Altered synthesis of interleukin-12 and type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles. J Infect Dis 185:13-19
64. Polack FP, Hoffman SJ, Crujeiras G, Griffin DE (2003a) A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat Med 9:1209-1213
65. Polack FP, Hoffman SJ, Moss WJ, Griffin DE (2003b) Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge. J Infect Dis 187:1794-1800
66. Potkay S, Ganaway JR, Rogers NG, Kinard R (1966) An epizootic of measles in a colony of rhesus monkeys (Macaca mulatta). Am J Vet Res 27:331-334
67. Premenko-Lanier M, Rota PA, Rhodes G, Verhoeven D, Barouch DH, Lerche NW, Letvin NL, Bellini WJ, McChesney MB (2003) DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. Virology 307:67-75
68. Premenko-Lanier M, Rota PA, Rhodes GH, Bellini WJ, McChesney MB (2004) Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J Infect Dis 189:2064-2071
69. Pütz MM, Bouche FB, De Swart RL, Muller CP (2003) Experimental vaccines against measles in a world of changing epidemiology. Int J Parasitol 33:525-545
70. Remfry J (1976) A measles epizootic with 5 deaths in newly-imported rhesus monkeys (Macaca mulatta). Lab Anim 10:49-57
71. Ruat C, Caillet C, Bidaut A, Simon J, Osterhaus ADME (2008) Vaccination of macaques with adjuvanted formalin-inactivated influenza A (H5N1) vaccines: protection against H5N1 challenge without disease enhancement. J Virol 82:2565-2569
72. Sabin AB, Fernandez de Castro J, Flores Arechiga A, Sever JL, Madden DL, Shekarchi I (1982) Clinical trials of inhaled aerosol of human diploid and chick embryo measles vaccine. Lancet 2:604
73. Sakaguchi M, Yoshikawa Y, Yamanouchi K, Sata T, Nagashima K, Takeda K (1986) Growth of measles virus in epithelial and lymphoid tissues of cynomolgus monkeys. Microbiol Immunol 30:1067-1073
74. Samb B, Aaby P, Whittle HC, Coll-Seck AM, Rahman S, Bennett J, Markowitz L, Simondon F (1995) Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 14:203-209
75. Schneider-Schaulies S, Klagge IM, Ter Meulen V (2003) Dendritic cells and measles virus infection. Curr Top Microbiol Immunol 276:77-101
76. Scott GBD, Keymer IF (1975) The pathology of measles in Abyssinian colobus monkeys (Colobus guereza): a description of an outbreak. J Pathol 117:229-233
77. Sergiev PG, Ryazantseva NE, Shroit IG (1960) The dynamics of pathological processes in experimental measles in monkeys. Acta Virol 4:265-273
78. Sharova OK, Rozina EE, Gordienko NM, Shteinberg LSH (1984) Effect of immunosuppression on morphological changes in CNS of monkeys infected with different measles virus vaccine strains. Acta Virol 28:144-147
79. Stittelaar KJ, Wyatt LS, De Swart RL, Vos HW, Groen J, Van Amerongen G, Van Binnendijk RS, Rozenblatt S, Moss B, Osterhaus ADME (2000) Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol 74:4236-4243
80. Stittelaar KJ, De Swart RL, Osterhaus ADME (2002a) Vaccination against measles: a neverending story. Expert Rev Vaccines 1:151-159
81. Stittelaar KJ, Vos HW, Van Amerongen G, Kersten GFA, Osterhaus ADME, De Swart RL (2002b) Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates. Vaccine 21:155-157
82. Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzaki Y, Nagai Y, Tashiro M (2000) Recovery of pathogenic measles virus from cloned cDNA. J Virol 74:6643-6647
83. Takeuchi K, Miyajima N, Nagata N, Takeda M, Tashiro M (2003) Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res 94:11-16
84. Tauraso NM (1973) Review of recent epizootics in nonhuman primate colonies and their relation to man. Lab Anim Sci 23:201-210
85. Valdespino-Gomez JL, De Lourdes Garcia-Garcia M, Fernandez de Castro J, Henao-Restrepo AM, Bennett J, Sepulveda-Amor J (2006) Measles aerosol vaccination. Curr Top Microbiol Immunol 304:165-193
86. Van Binnendijk RS, van der Heijden RWJ, Van Amerongen G, UytdeHaag FGCM, Osterhaus ADME (1994) Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis 170:443-448
87. Van Binnendijk RS, van der Heijden RWJ, Osterhaus ADME (1995) Monkeys in measles research. Curr Top Microbiol Immunol 191:135-148
88. Van Binnendijk RS, Poelen MCM, Van Amerongen G, De Vries P, Osterhaus ADME (1997) Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis 175:524-532
89. Von Pirquet CE (1908) Das Verhalten der kutanen Tuberkulin-reaktion während der Masern. Dtsch Med Wochenschr 34:1297-1300
90. Warthin AS (1931) Occurrence of numerous large giant cells in the tonsils and pharyngeal mucosa in the prodromal stage of measles. Arch Pathol 11:864-874
91. Welshman MD (1989) Measles in the cynomolgus monkey (Macaca fascicularis). Vet Rec 124:184-186
92. WHO (2007) Manual for the laboratory diagnosis of measles and rubella virus infection. WHO/IVB/07.01, Geneva
93. Yamanouchi K, Egashira Y, Uchida N, Kodama H, Kobune F, Hayami M, Fukuda A, Shishido A (1970) Giant cell formation in lymphoid tissues of monkeys inoculated with various strains of measles virus. J Med Sci Biol 23:131-145
94. Yamanouchi K, Chino F, Kobune F, Kodama H, Tsuruhara T (1973) Growth of measles virus in the lymphoid tissues of monkeys. J Infect Dis 128:795-799
95. Zhu Y, Heath J, Collins J, Greene T, Antipa L, Rota PA, Bellini W, McChesney MB (1997) Experimental measles II. Infection and immunity in the rhesus macaque. Virology 233:85-92
96. Zhu Y-D, Rota P, Wyatt LS, Tamin A, Rozenblatt S, Lerche N, Moss B, Bellini W, McChesney M (2000) Evaluation of recombinant vaccinia virus - measles vaccines in infant rhesus macaques with preexisting measles antibody. Virology 276:202-213